Cora Tucker, 6, of Matthews, was one of the neuroblastoma patients enrolled in a clinical trial that led to the approval of a new drug called Unituxin.
Cora Tucker, 6, of Matthews, was one of the neuroblastoma patients enrolled in a clinical trial that led to the approval of a new drug called Unituxin. Carolinas HealthCare System
Cora Tucker, 6, of Matthews, was one of the neuroblastoma patients enrolled in a clinical trial that led to the approval of a new drug called Unituxin. Carolinas HealthCare System